Global Cell Culture Market 2018-2022 | Demand for 3D Cell Culture to Spur Growth | Technavio

Technavio has published a new market research report on the global cell culture market from 2018-2022. (Graphic: Business Wire)

LONDON--()--The global cell culture market 2018-2022 is expected to post a CAGR of more than 9% during the forecast period, according to the latest market research report by Technavio.

A key factor driving the growth of the market is the increasing demand for 3D cell culture. 3D cell culture is a process of growing biological cells in an artificially created environment. 3D cell culture closely resembles the normal cell morphology and hence is being used in various research fields. Moreover, 3D cell culture provides detailed information on cell growth, which helps in the prediction of drug resistance. Additionally, stem cell research, viral pathogenesis, viral growth, infection, and pathogen-host interactions can also be studied using 3D models.

This market research report on the global cell culture market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the increase in infectious diseases as one of the key emerging trends in the global cell culture market:

Global cell culture market: Increase in infectious diseases

The prevalence of infectious diseases is increasing at a fast rate due to the growing global population. There have been several cases of spread of virus such as, Ebola, severe acute respiratory syndrome (SARS), swine flu, Zika, and Lasse fever, which are considered global pandemics. These infections spread at a fast rate, generally in less than a week.

“Treating pandemic and epidemic infectious diseases require vaccine or drugs. This has led to R&D of antiviral drugs, cell-based therapies, and vaccines by using cell culture methods. The preference for cell-based vaccines has increased because the process produces vaccines in the shortest amount of time as it is not dependent on an egg supply or limited by the selection of vaccine viruses that are adopted for the growth in eggs. All these advantages have resulted in an increase in the use of cell culture techniques to treat and prevent infectious diseases,” says a senior analyst at Technavio for research on life science research tools.

Global cell culture market: Segmentation analysis

This market research report segments the global cell culture market by product (consumables and equipment) and geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2017 with a market share of more than 43%, which is mostly contributed by North America. The market in the region is driven by the factors such as rapidly increasing infectious diseases demanding the need of antibiotics and other drugs; and increasing use of cell-based products to treat various chronic diseases such as cancer, tuberculosis, diabetes, and cardiovascular diseases. Moreover, the presence of sophisticated infrastructure and growing R&D activities are likely to spur the market growth in the Americas.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market sizing
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global cell culture market 2018-2022 is expected to post a CAGR of more than 9% during the forecast period, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com